Cargando…
Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis
BACKGROUND: Objectives were to describe the proportion of deaths due to treatment-related mortality (TRM) and to identify risk factors and probable causes of TRM among paediatric cancer deaths in a population-based cohort. METHODS: We included children with cancer ⩽18 years diagnosed and treated in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318976/ https://www.ncbi.nlm.nih.gov/pubmed/28095399 http://dx.doi.org/10.1038/bjc.2016.443 |
_version_ | 1782509289848438784 |
---|---|
author | Pole, Jason D Gibson, Paul Ethier, Marie-Chantal Lazor, Tanya Johnston, Donna L Portwine, Carol Silva, Mariana Alexander, Sarah Sung, Lillian |
author_facet | Pole, Jason D Gibson, Paul Ethier, Marie-Chantal Lazor, Tanya Johnston, Donna L Portwine, Carol Silva, Mariana Alexander, Sarah Sung, Lillian |
author_sort | Pole, Jason D |
collection | PubMed |
description | BACKGROUND: Objectives were to describe the proportion of deaths due to treatment-related mortality (TRM) and to identify risk factors and probable causes of TRM among paediatric cancer deaths in a population-based cohort. METHODS: We included children with cancer ⩽18 years diagnosed and treated in Ontario who died between January 2003 and December 2012. Deaths were identified using a provincial registry, the Pediatric Oncology Group of Ontario Networked Information System. Probable causes of TRM were described. RESULTS: Among the 964 deaths identified, 821 were included. The median age at diagnosis was 6.6 years (range 0–18.8) and 51.8% had at least one relapse. Of the deaths examined, TRM occurred in 217/821 (26.4%) while 604/821 (73.6%) were due to progressive cancer. Deaths from TRM did not change over time. Using multiple regression, younger age, leukaemia diagnosis and absence of relapse were independently positively associated with TRM. The most common probable causes of TRM were respiratory, infection and haemorrhage. CONCLUSIONS: TRM was responsible for 26.4% of deaths in paediatric cancer. Underlying diagnosis, younger age and absence of relapse were associated with TRM and causes of TRM differed by diagnosis group. Future work should evaluate TRM rate and risk factors among newly diagnosed cancer patients. |
format | Online Article Text |
id | pubmed-5318976 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-53189762018-02-14 Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis Pole, Jason D Gibson, Paul Ethier, Marie-Chantal Lazor, Tanya Johnston, Donna L Portwine, Carol Silva, Mariana Alexander, Sarah Sung, Lillian Br J Cancer Epidemiology BACKGROUND: Objectives were to describe the proportion of deaths due to treatment-related mortality (TRM) and to identify risk factors and probable causes of TRM among paediatric cancer deaths in a population-based cohort. METHODS: We included children with cancer ⩽18 years diagnosed and treated in Ontario who died between January 2003 and December 2012. Deaths were identified using a provincial registry, the Pediatric Oncology Group of Ontario Networked Information System. Probable causes of TRM were described. RESULTS: Among the 964 deaths identified, 821 were included. The median age at diagnosis was 6.6 years (range 0–18.8) and 51.8% had at least one relapse. Of the deaths examined, TRM occurred in 217/821 (26.4%) while 604/821 (73.6%) were due to progressive cancer. Deaths from TRM did not change over time. Using multiple regression, younger age, leukaemia diagnosis and absence of relapse were independently positively associated with TRM. The most common probable causes of TRM were respiratory, infection and haemorrhage. CONCLUSIONS: TRM was responsible for 26.4% of deaths in paediatric cancer. Underlying diagnosis, younger age and absence of relapse were associated with TRM and causes of TRM differed by diagnosis group. Future work should evaluate TRM rate and risk factors among newly diagnosed cancer patients. Nature Publishing Group 2017-02-14 2017-01-17 /pmc/articles/PMC5318976/ /pubmed/28095399 http://dx.doi.org/10.1038/bjc.2016.443 Text en Copyright © 2017 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
spellingShingle | Epidemiology Pole, Jason D Gibson, Paul Ethier, Marie-Chantal Lazor, Tanya Johnston, Donna L Portwine, Carol Silva, Mariana Alexander, Sarah Sung, Lillian Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis |
title | Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis |
title_full | Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis |
title_fullStr | Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis |
title_full_unstemmed | Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis |
title_short | Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis |
title_sort | evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318976/ https://www.ncbi.nlm.nih.gov/pubmed/28095399 http://dx.doi.org/10.1038/bjc.2016.443 |
work_keys_str_mv | AT polejasond evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT gibsonpaul evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT ethiermariechantal evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT lazortanya evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT johnstondonnal evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT portwinecarol evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT silvamariana evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT alexandersarah evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis AT sunglillian evaluationoftreatmentrelatedmortalityamongpaediatriccancerdeathsapopulationbasedanalysis |